Showing results (151-160 of 167) with videos related to
Sort By:
Pageof 17
Frontiers in Immunology|January 27, 2023
Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patientsZhaodi Nan, Yu Dou, Anwei Chen, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 27, 2025
ARL5B Drives Esophageal Squamous Cell Carcinoma Progression via ROCK1-SREBP1-Mediated Lipid Metabolic ReprogrammingXinyue Ma, Yanfei Sun, Hongyuan Mao, et al.Oncotarget|April 14, 2017
Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomyPengxiang Chen, Lihui Han, Cong Wang, et al.British Journal of Cancer|February 21, 2018
miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2Cong Wang, Wenxue Zhang, Lin Zhang, et al.British Journal of Cancer|November 11, 2016
miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2Cong Wang, Wenxue Zhang, Lin Zhang, et al.Translational Lung Cancer Research|November 7, 2024
TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trialBaiqiang Dong, Long Chen, Qingsong Pang, et al.Journal of Clinical Pathology|April 1, 2017
miR-10b is a prognostic marker in clear cell renal cell carcinomaHeba W Z Khella, Nicole Daniel, Leza Youssef, et al.Oncotarget|September 24, 2017
The effects of air pollution on mortality and clinicopathological features of esophageal cancerXiaochen Huang, Shanghui Guan, Jiangfeng Wang, et al.JTO Clinical and Research Reports|November 17, 2025
AdvanTIG-204: A Phase 2, Randomized, Open-Label Study of Ociperlimab Plus Tislelizumab and Concurrent Chemoradiotherapy Versus Tislelizumab and Concurrent Chemotherapy Versus Concurrent Chemoradiotherapy in First-Line Limited-Stage SCLCYouling Gong, Qingsong Pang, Rong Yu, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 7, 2016
Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinomaCong Wang, Qingbao Li, Fang Liu, et al.Pageof 17